Janssen Pharmaceuticals, Inc.
Records under this name other than the patents Janssen Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 101 patents it holds.
Back to Janssen Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,114,138 | 1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′] bipyridinyl-2′-ones Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,987,276 | Novel Substituted Triazolyl Piperazine and Triazolyl Piperidine Derivatives as Gamma Secretase Modulators Formerly held In force · High confidence | In force | High confidence | |
| US 9,181,245 | SUBSTITUTED PYRIDO[1,2-a]PYRAZINES AND SUBSTITUTED PYRIDO[1,2-a][1,4]DIAZEPINES FOR THE TREATMENT OF (INTER ALIA) ALZHEIMER'S DISEASE Formerly held In force · High confidence | In force | High confidence | |
| US 12,173,025 | Substituted Nucleosides, Nucleotides and Analogs Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,143,693 | Dosing Regimen for Missed Doses for Long-Acting Injectable Paliperidone Esters Formerly held In force · High confidence | In force | High confidence | |
| US 10,696,632 | Mono- or Di-Substituted Indole Derivatives As Dengue Viral Replication Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 10,919,854 | Mono- or Di-Substituted Indole Derivatives as Dengue Viral Replication Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 12,172,959 | Mono- or Di-Substituted Indole Derivatives as Dengue Viral Replication Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,484,582 | Methods and Compositions for Immune Protection Against Extra-Intestinal Pathogenic E. Coli Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,583,185 | Methods and Compositions for Immune Protection Against Extra-Intestinal Pathogenic E. Coli Formerly held In force · High confidence | In force | High confidence |